A Message From Your Friends At The Southeast AETC: Our hearts go out to those in our community who were affected by the hurricanes. If you have patients that are having trouble accessing HIV services during this time, we urge you to utilize HRSA’s Find a Ryan White Provider tool to help navigate them to services nearby.

Participant Login
View Events Calendar

Health Maintenance Recommendations for PWH

Table of Contents

  • Vaccine Recommendations
    • Flu vaccine
    • Hepatitis A
    • Hepislav-B
      Hepatitis B
    • Human Papilloma Virus
    • Meningococcus
    • Diphtheria & Tetanus (Td)
    • Varicella Zoster recombinant vaccine
    • Pneumococcus
  • Screening Recommendations
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Cervical Cancer
    • Anal Cancer
    • Abdominal Aortic Aneurysm
    • Hepatitis C
    • Osteoporosis (DEXA Scan)
    • Dyslipidemia
    • Diabetes Mellitus (Hemoglobin A1C)

Editors

  • Kassem Bourgi, MD
  • Stephen Raffanti, MD, MPH

Flu Vaccine

  • Who: All PWH
  • Frequency: Annually
  • Comments: Use high-dose inactivated vaccine for age: 65+ years.

Hepatitis A

  • Who: MSM, PWID, Persons with liver disease (including HBV and HCV)
  • Frequency: 2 doses: 0 and 6 months
  • Comments: Consider vaccination for all PLWH.

Hepislav-B
Hepatitis B

  • Who: Non-immune patients (1)
  • Frequency: 2 doses: one month apart
  • Comments: Recheck serology at least 4 weeks after last dose. If surface AB levels are not protective: repeat vaccine series.

Human Papilloma Virus

  • Who: PWH, both genders, age: 13 – 45 years
  • Frequency: 3 doses: 0, 1 and 6 months

Meningococcus

  • Who: All PWH
  • Frequency: 2 doses: Menveo or Menactra at least 8 – 12 weeks apart, booster in 5 years
  • Comments: Does not cover meningococcus serotype B (outbreaks, asplenics).

Diphtheria & Tetanus (Td)

  • Who: All PWH
  • Frequency: 1 dose every 10 years
  • Comments: One-time substitution of Td with TdaP (acellular pertussis).

Varicella Zoster recombinant vaccine

  • Who: Age > 50 Years & CD4 > 200 cells/mm3
  • Frequency: 2 doses: 2 – 6 months apart
  • Comments: Limited evidence on efficacy and safety but likely better than live vaccine.

Pneumococcus

  • Who: All PWH
  • Frequency: 2 doses: PCV13 followed by PPSV23 at least 8 weeks apart. PPSV23 boosters in 5 years & at age 65 years.
  • Comments: Consider deferring PPSV23 until CD4 > 200 cells/mm3. If PPSV23 given first, give PCV13 after 12 months.
  1. Hepatitis B non-immune patients include: HBsAg/Ab(-) HBcAB(-) & HBsAg/Ab(-) HBcAB(+)HBVPCR(-)
  2. Recombinant Zoster Vaccine (Shingrix) is not currently recommended by Advisory Committee on Immunization Practices (ACIP) for PWH.
    Abbreviations: PLWH: Persons Living with HIV; MSM: Men Who Have Sex with Men; PWID: Persons Who Inject Drugs; HBV: Hepatitis B Virus; HCV:
    Hepatitis C Virus; AB: Antibody; PCV13: Prevnar 13; PPSV23: Pneumovax; HBsAg/Ab: Hepatitis B surface antigen &antibody; HBcAB: Hepatitis B core antibody
  3. Abbreviations: PLWH: Persons Living with HIV; MSM: Men Who Have Sex with Men; PWID: Persons Who Inject Drugs; HBV: Hepatitis B Virus; HCV: Hepatitis C Virus; AB: Antibody; PCV13: Prevnar 13; PPSV23: Pneumovax; HBsAg/Ab: Hepatitis B surface antigen &antibody; HBcAB: Hepatitis B core antibody

Breast Cancer

  • Who: Women age ≥ 40 years
  • Frequency: Annually

Lung Cancer

  • Who: PWH age 55 – 80 with 30 pack-year smoking history
  • Frequency: One-time screening with lowdose CT Lung
  • Comments: Applicable if quit smoking < 15 years ago.

Colorectal Cancer

  • Who: All PWH age≥ 50 years
  • Frequency: Colonoscopy every 10 years if normal
  • Comments: Consider earlier screening for patients with strong family history & patients with IBD.

Cervical Cancer

  • Who: Women 21 – 65 years
  • Frequency: Pap Smear with HPV testing: At initiation of care, repeat in 6 months & annually thereafter
  • Comments: Not required after hysterectomy unless done for cancerous or precancerous disease.

Anal Cancer

  • Who: PWH, of both genders, age≥ 25 years, who engage in receptive anal intercourse
  • Frequency: Pap Smear with HPV testing. Screening data is lacking
  • Comments: Screen only if highresolution anoscopy + biopsy & ablative treatments are available.

Abdominal Aortic Aneurysm

  • Who: Men age 65 – 75 years who ever smoked
  • Frequency: One-time Abdominal Ultrasound screening
  • Comments: Not required if patient has recent abdominal CT scan without evidence of aortic aneurysm.

Hepatitis C

  • Who: All PWH
  • Frequency: HCV Antibody on initiation of care and then annually

Osteoporosis (DEXA Scan)

  • Who: PLWH, both genders, age: ≥ 50 years or ≥ 40 years with FRAX score ≥ 10%
  • Frequency: HCV Antibody on initiation of care and then annually
  • Comments: For women: start at age 50 or 10 years after menopause.

Dyslipidemia

  • Who: All PWH
  • Frequency: Baseline, within 1-3 months from starting new regimen then annually.
  • Comments: Consider TG treatment for levels ≥ 1,000 mg/dL & statin if ASCVD ≥ 7.5%.

Diabetes Mellitus (Hemoglobin A1C)

  • Who: All PWH
  • Frequency: Baseline, within 1-3 months from starting new regimen then annually.
  • Comments: Consider starting diabetes treatment at Hemoglobin A1C ≥ 7 – 7.5%.

4. Abbreviations: PLWH: Persons Living with HIV; HPV: Human Papilloma Virus; IBD: Inflammatory Bowel Disease; TG: Triglycerides; HCV: Hepatitis C
5. FRAX Risk Assessment Tool: https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9,
6. ASCVD (Atherosclerotic Cardiovascular Disease) Risk Assessment Tool: http://www.cvriskcalculator.com/